Chapter 17. Clinical Applications of Gene Therapy in Cancer: Modification of Sensitivity to Therapeutic Agents
- Peter J. Quesenberry4,
- Gary S. Stein4,
- Bernard G. Forget5,
- Sherman M. Weissman5
Published Online: 13 MAY 2002
DOI: 10.1002/0471223956.ch17
Copyright © 1998 by Wiley-Liss, Inc.
Book Title

Stem Cell Biology and Gene Therapy
Additional Information
How to Cite
Licht, T., Gottesman, M. M. and Pastan, I. (2002) Clinical Applications of Gene Therapy in Cancer: Modification of Sensitivity to Therapeutic Agents, in Stem Cell Biology and Gene Therapy (eds P. J. Quesenberry, G. S. Stein, B. G. Forget and S. M. Weissman), John Wiley & Sons, Inc., New York, USA. doi: 10.1002/0471223956.ch17
Editor Information
- 4
University of Massachusetts, Worcester, Massachusetts
- 5
Yale University School of Medicine, New Haven, Connecticut
Publication History
- Published Online: 13 MAY 2002
- Published Print: 27 AUG 1998
ISBN Information
Print ISBN: 9780471146568
Online ISBN: 9780471223955
- Summary
- Chapter
Keywords:
- cancer;
- gene therapy;
- clinical applications;
- anticancer drugs;
- chemoresistance;
- proteins;
- drug resistance genes;
- interference;
- hematopoietic cells
Summary
An increasing number of mechanisms that render cells chemoresistant are being uncovered. The authors of this chapter focus on mechanisms of drug resistance that can potentially be overcome. Strategies to modify chemoresistance are aimed at either interfering with transcription or translation of the respective genes or at modulating the function of their products.
